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ABSTRACT
The fourth hand transplant recipient in Louisville lost his graft at nine months
post transplant from ischemia due to severe graft arteriopathy. Conventional imaging
techniques and clinical measurements, including CT angiography and measurements of
brachial indices via ultrasound, did not indicate that the patient was in such a severe
condition in the days prior to amputation. Histological analysis of tissue from the
amputated graft revealed massive intimal hyperplasia, a hallmark of chronic rejection.
The purpose of this study was to describe a method to allow non-invasive monitoring of
wall thicknesses in the radial, ulnar, palmar arch, and digital arteries of the transplanted
hand.
A novel ultrasound biomicroscopy unit (Vevo 2100) was used to image the blood
vessels of the transplanted and native hands in four hand transplant recipients, ranging
from 16 months to 11 years post transplant. The unit has a potential resolution of 30 µm,
which allowed measurement of the intima and media layers of the arteries.
The intima, media, and lumen measurements were compared in the native and
transplanted hand in all four patients. Significant increases in intima thickness were
found in the transplanted hands. In addition, the transplanted hand had significantly
higher intima to lumen diameter ratios. From Doppler waveforms, it was found that that
peak velocities were lower in the transplanted hand. Finally, hoop stress calculations
revealed that the hoop stress seen in the arterial walls was lower in the transplanted hand.
The ultrasound biomicroscopy unit provided an accurate, repeatable, and realtime method to investigate the arteriopathy of hand transplant patients. In the future, it
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will provide a way for clinicians to monitor the progression of arteriopathy in the hand,
including intimal hyperplasia.
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I. INTRODUCTION
The loss of a limb is a potentially devastating event in a person’s life that often results
in profound physical, psychological, and occupational consequences. There are
approximately 1,908 upper limb amputations performed each year. The majority of
upper limb amputations are necessary due to traumatic injury or congenital disorders
(Adams, 1999).
Conventional treatment options available for upper limb amputees include: 1)
reconstructive surgery using their own tissue to repair the damage; or, 2) the use of a
prosthetic device. Recently, a third option, composite tissue allotransplantation (CTA),
referring to the transplantation of allogenic grafts made up of more than one type of
tissue (i.e., skin, muscle, and bone), has become available (Kaufman, 2009). CTA
combines the principles of microsurgical reconstruction and human organ transplantation.
CTA has the potential to be useful for functional restoration of patients with severe tissue
loss as encountered with massive burns, traumatic injuries, congenital anomalies, and
following tumor resection. Many of these patients simply do not have enough autologous
tissue for the surgeon to use. For example, instead of a surgeon having the situation
where he would need to reconstruct a jawbone by using bone from the tibia, the surgeon
could replace “like tissue” with “like tissue” in CTA. The ability to reliably and safely
carry out CTA would revolutionize reconstructive surgery.
The field of CTA transplantation is still very new. There have only been ~44 hands
transplanted worldwide. The Louisville CTA program, which is a collaboration between
the surgeons at Kleinert and Kutz and Associates, the Christine M. Kleinert Institute for
Hand and Microsurgery, the University of Louisville, and Jewish Hospital and St. Mary’s
1

Healthcare, was the first center to perform hand transplantations in the United States and
have transplanted five hands, with their first transplant occurring in January 1999. Other
types of CTA grafts including abdominal walls, larynx and knees have also been
transplanted. Although CTA has many benefits, CTA also introduces new complications
to consider in tissue reconstruction such as immunologic, ethical, and psychological
issues (Petit, 2003).
Currently, recipients of CTA must receive systemic immunosuppressive treatment for
the life of the graft, which has potentially serious side effects. Finding an effective and
nontoxic immunosuppressive treatment has been a limiting factor in organ
transplantation. Composite tissue allografts, unlike solid organ transplants, are
heterogeneous and are composed of tissues that express varying degrees of antigenicity.
Thus, increasing antigenic sensitivity of CTA complicates the development of an ideal
immunosuppressive treatment further (Petit, 2003).
Allograft patients are at risk for acute and chronic graft rejection,
immunosuppressive toxicity, and graft-versus-host disease (GVHD). Physicians use
several methods to check for signs and symptoms of rejection. In particular, they look
for arteriopathy that could threaten the blood flow and viability to the graft. Signs of
rejection are first suspected upon visual inspection of the transplanted hand. Then, other
diagnostic measures, such as brachial indices, histology, CT, and MR angiography, are
used in order to confirm or disprove the suspicion. The gold standard for diagnosing
rejection in CTA is histological evaluation of skin biopsies (Cendales 2007). Due to the
invasiveness of taking a biopsy for histological evaluation, the other mentioned
diagnostic measures are performed first.
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Physicians use brachial indices to evaluate vascular perfusion of the hand and
digits in several conditions such as rheumatoid arthritis, systemic lupus, Berger’s disease,
atherosclerosis, and trauma. In each of these conditions, vascular supply is decreased.
The brachial indices are obtained from an ultrasound that measures segmental blood
pressure of the arteries in the arm and hand. For hand transplant, digital brachial indices
are used to eliminate the suspicion of any obstructive phenomenon which may
compromise perfusion. This could include an anastomosic site with developing stenosis
or advanced intimal hyperplasia. The brachial indices are pressure ratios, which may not
provide much valuable information regarding the patency of the vessels investigated.
CT and MR angiography are noninvasive imaging techniques that provide a
visualization of the arterial tree to assess patency of the blood vessels in the graft.
However, only the late stages of chronic rejection would show observable differences in
the patency of these arteries. To determine the status of the graft, it is important to
examine the arteriopathy present. In transplants, arteriopathy generally manifests as
cellular growth in the arterial wall. The arterial wall is only several micrometers thick.
Thus, to detect the arteriopathy present in hand transplant patients, the resolution of an
imaging technique must be on the micrometer range. The resolution of both CT and MR
angiography is not sufficient to image the arterial wall; and, therefore, it cannot be used
to detect the arteriopathy present in hand transplant patients.
Arterial intimal hyperplasia (IH) refers to any cells that form layers between the
endothelial lining and internal elastic membrane of the arterial wall. Arterial neointimal
formation or intimal hyperplasia is consistently present in graft vascular disease
(Subbotin, 2007). In addition, it is the main manifestation of chronic rejection in solid
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organ transplantation (Demetris, 1998; Geraghty, 1996). Progression of intimal
hyperplasia can lead to occluded arteries or stenosis of vascular grafts (Subbotin, 2007;
Demetris, 1998; Geraghty, 1996; Haruguchi, 2003).
The exact pathology of intimal hyperplasia remains unclear. There are a number of
factors that are suspected to either initiate or aggravate the progression of intimal
thickening. Intimal hyperplasia is known to develop distal to arterial bypass graft
anastomoses. Several mechanical factors including low shear stress, oscillating shear
forces, high wall shear stress gradients, and compliance mismatch have been attributed to
intimal hyperplasia formation (Haruguchi, 2003; Kohler, 1992; Glagov, 1997; Keynton,
1995). For transplant patients, the introduction of alloantigens and an activated immune
system are thought to be the underlying mechanism of graft vascular disease, which
presents itself as intimal hyperplasia (Subbotin, 2007).
Monitoring the progression of intimal hyperplasia in the past has been difficult.
However, this method has several drawbacks, most importantly, unacceptable morbidity
at the biopsy site. This is especially true for deep biopsies. A patient can undergo deep
biopsy a limited number of times since the procedure permanently removes a section of
the arterial tree. In addition, a histological analysis of an arbitrary arterial slice may not
provide an accurate representation of the level of arteriopathy throughout the same artery
longitudinally. Intimal hyperplasia can be patchy, meaning that it may be thicker in some
areas and much thinner in the same artery just a few centimeters away. Finally, a biopsy
does not give a real-time indication of the level of arteriopathy. The tissue sample
excised must be sent to a laboratory for analysis, and the patient must wait for the results.
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Thus, identifying or developing a new, non-invasive, high resolution system for
measuring intimal hyperplasia thickness in arterial vessels would significantly impact the
field of CTA. A system with these capabilities would enable the clinician to carefully
monitor the progression of the IH post-operatively. As a result, the clinician could
properly prescribe or modify the therapeutic regimen to retard, stop or reduce the growth
of IH in the transplanted graft.

1.1 Purpose of the Study
The purpose of this study was to identify and characterize a repeatable, real-time,
non-invasive method, Ultrasound Biomicroscopy (UBM) system (Vevo 2100,
Visualsonics, Toronto, Canada) to measure intimal hyperplasia in CTA grafted patients
and compare levels of intimal hyperplasia between the native and transplanted hands. In
addition, measurements from the UBM are to be compared with the digital brachial index
measurements to investigate the validity of using digital brachial indices as an indirect
assessment of arterial patency.

1.2 Hypotheses
1) The intima thicknesses are significantly higher in the transplanted arm
than in the native arm in hand transplant patients, using the patient as his
own control.
2) The intima-to-lumen diameter ratios are significantly higher in the arm
receiving the CTA graft than in the native arm of hand transplant patients.
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3) Intima thickness and lumen diameter more accurately indicate the
presence of arteriopathy compared to brachial indices, the current gold
standard.
4) Brachial indices do not directly correlate to CTA arteriopathy.

1.3 Significance of Study
Chronic rejection is a poorly understood phenomenon and difficult to monitor. In
previous studies, chronic rejection was not considered to be a significant problem in CTA
(Kaufman, 2009; Petit, 2003; Petruzzo, 2008). However, recent event in our group have
indicated that chronic rejection via excessive hyperplastic growth of the intima does
occur in CTA graft patients. Conventional vascular imaging techniques are unable to
detect arteriopathy. Thus, a suitable method to detect and observe changes in the arterial
wall will provide clinicians with the opportunity to detect chronic rejection in composite
tissue allotransplantation early, which will enable the clinicians to modify the patient’s
therapeutic regimen in order to halt or slow the progression of the threatening
arteriopathy. In addition, a safe and non-invasive intimal hyperplasia measurement
technique can provide a means to better understand what normal levels of intimal
hyperplasia are and help in the identification of risk factors involved in IH development.
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II. LITERATURE REVIEW AND BACKGROUND

There are approximately 1.7 million people living with limb loss in the United
States (Adams, 1999). There is a much smaller group of upper-limb amputees, given that
approximately 1, 908 upper-limb amputations are performed each year compared to
56,912 lower-limb amputations. The majority of all trauma-related amputations (about
68.6 percent) are upper-limb amputations. Risk of traumatic amputations increase with
age and is higher for men than women (NLLIC, 2008).
Treatment options available for individuals that have lost a hand or limb include
reconstructive surgery using their own tissue to repair the damage or the use of a
prosthetic device. Recently, another option has been introduced clinically, composite
tissue allotransplantation (CTA). Referring to all non-organ transplants, CTA combines
the principles of microsurgical reconstruction and human organ transplantation. The
transplantation tissue for repairing the lost limb is taken from deceased donors that have
also donated their hearts, kidneys or other types of organs to carefully selected patients
(Petit, 2003). CTA aims to address the limitations associated with reconstructive surgery
by using native tissue, including poor functional and aesthetic results, multiple revisions,
long rehabilitation times, and donor site morbidity (Breidenbach, 2008). However, CTA
also introduces new complexities to consider in tissue reconstruction such as
immunologic, ethical, and psychological issues (Petit, 2003).
Allograft patients are at risk for graft-versus-host disease (GVHD),
immunosuppressive toxicity, and acute and chronic rejection. To prevent these
conditions, the recipient of a CTA graft must comply with an immunosuppressive
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protocol indefinitely, which has potentially serious side effects. The search for an
efficient yet nontoxic immunosuppressive treatment has been the primary limitation in
the field of transplantation. Unlike solid organ transplants, composite tissue allografts are
histologically heterogeneous and are composed of tissues that express varying degrees of
antigenicity, such as skin and muscle, which are extremely antigenic. The greater
antigenicity of composite tissues further complicates the development of desirable
immunosuppression regimens (Petit, 2003).
GVHD occurs when donor T cells respond to protein on host cells that are
genetically specific to the host (Ferrara, 2009). The principal proteins involved are the
human leucocyte antigens (HLAs), which are highly polymorphic and are encoded by the
major histocompatibility complex (MHC). Class I HLA (A, B, and C) proteins are
expressed on nearly all nucleated cells of the body. Class II proteins (DR, DQ, and DP)
are mainly expressed on haemopoietic cells (B cells, dendritic cells, and monocytes), but
their expression can be induced on several other cell types after inflammation or injury.
The frequency of acute GVHD is directly correlated to the degree of mismatch between
HLA proteins.
Typically, a triple-drug combination therapy has been used for CTA
immunosuppression, similar to the standard approach used in solid organ transplantation.
Each of the hand transplants reported to the International Registry on Hand and
Composite Tissue Transplantation (IRHCTT) before 2009 utilized a combination of
tacrolimus, mycophenolate mofetil (MMF), and a steroid (usually prednisone) in the first
period after transplantation. The patients were usually weaned-off of the steroids, if
possible, to reduce severity of the side effects.

8

The immunosuppressive drugs that CTA patients take to protect the viability of
their graft act nonspecifically to suppress the entire immune system (Ravindra, 2009).
This results in an associated risk of tumors, opportunistic infections, and organ toxicity.
The hand transplant registry reports opportunistic infections in 63.6% and metabolic
complications in 50% of the patients. The most serious complications that have been
reported have been steroid-related aseptic necrosis of both hips in a patient (Gonzalez,
2005) and renal compromise in the first face transplant recipient (Dubernard, 2007). The
main challenges for CTA are minimizing immunosuppression while also preventing acute
and chronic rejection (Ravindra, 2009).
Both acute and chronic rejection episodes are first suspected upon visible signs
on the skin of the transplanted hand, this typically manifests as a maculopapular rash (flat
red area on the skin covered with small confluent bumps). Rejection episodes are then
confirmed by histological evaluation of a skin biopsy (Breidenbach, 2008). Acute
rejection episodes occur in some degree in all transplants. However, recurrent episodes
may be associated with a more severe condition, chronic rejection. Chronic rejection is
the process of long-term loss of function of the transplant. Care must be taken to watch
for signs of both acute and chronic rejection. A large amount of research has been
dedicated to the signs, symptoms, and treatments for acute and chronic rejection.

2.1 Acute Rejection
Acute rejection is a T cell-mediated attack of the allograft by the recipient’s
immune system. Acute rejection results in graft damage and loss of the graft if not
promptly treated with a more aggressive immunosuppression therapy. Episodes of acute
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rejection are characterized by cutaneous lesions, which generally begin as faint pink
macules that may develop into red infiltrated papules with or without swelling of the
graft. The majority of acute rejection episodes occur in the first year after
transplantation. Acute rejection episodes occurred in about 85% of the IRHCTT patients
within the first year; many patients had multiple acute rejection episodes in this first year
post-transplant. These episodes were easily reversed with an increase of
immunosuppression (Ferrara, 2009). The rejection episodes were reversed in all
compliant hand transplant patients when the episodes were promptly reported and treated
(Petruzzo, 2008). Other acute rejection episodes occurred when patients did not comply
with their immunosuppressive drug regimen or when their drug therapy was reduced for
various reasons (i.e., to reduce side effects or as a team decision) (Petruzzo, 2008).

2.2 Chronic Rejection
Chronic rejection has remained a poorly characterized event that usually occurs
late after transplantation. Classical features of chronic rejection that differentiate it from
acute rejection are intimal hyperplasia and interstitial fibrosis (Petruzzo, 2008). Chronic
rejection mechanisms have been shown to be both cellular- and humoral-mediated that
manifest by vascular changes (Breidenbach, 2008). Clinical and experimental studies
have identified pathological markers characteristic of chronic rejection in solid organ
transplantation (Geraghty, 1996; Merville, 2005; Hayry, 1991; Ross, 1993). The
common factor in these studies, which marks the defining feature of chronic rejection,
was the progressive thickening of the arterial walls within the affected organ due to
neointimal hyperplasia. For example, in chronic renal allograft dysfunction (CRAD), the
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vascular injuries were characterized by thickening of the arterial walls with a subintimal
accumulation of connective tissue, a penetration of mononuclear cells and a proliferation
of myofibroblasts. These events lead to a dangerous narrowing of the arterial lumen
(Merville, 2005).
Chronic rejection still disastrously affects the outcome of transplantation and
there is no suitable treatment to stop it. The main pathology of chronic rejection, graft
vascular disease (which often presents as intimal hyperplasia), is thought to be caused by
the introduction of alloantigens and an activated immune system. Non-immunological
factors have been considered to be exacerbating and possibly predictive of graft vascular
disease. However, these factors have not been considered as a pathogenic cause of
chronic rejection (Subbotin, 2007).
The underlying mechanism in the development of intimal hyperplasia has not
been fully understood. A common theory has been that vascular smooth muscle cells
from the media of the arterial wall migrate into the intima. The cause for this potential
mechanism has remained unknown. Scientists have theorized that it could be
immunologically and/or mechanically mediated. Very few studies have performed
experiments to confirm or dismiss this theory because of the inherent difficulty in
assessing the progression of intimal hyperplasia, which produces vascular wall changes
on the order of 10-100s of micrometers, in a functioning transplant (Geraghty, 1996).

2.3 Intimal hyperplasia
Arterial intimal hyperplasia (IH) refers to cells that form a multi-layer
compartment within the internal elastic membrane of the arterial wall (in the intima layer)
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and express alpha-smooth-muscle actin (Stary, 1992: Subbotin, 2007). The thickened
arterial wall results in a narrowing of the lumen diameter, which changes the flow
patterns within the artery and eventually leads to the occlusion of the arterial vessel by
thrombosis (Geraghty, 1996). IH is the main pathological remodeling found in
complications after angioplasty, bypass operations and stenting; and once initiated, it is
not treatable (Subbotin, 2007; Demetris, 1998; Geraghty, 1996; Haruguchi, 2003). In
addition, IH can negatively affect other disease conditions such as peripheral artery
occlusive disorder and graft vascular disease in transplantation (Subbotin, 2007;
Haruguchi, 2003). Small levels of intimal hyperplasia are normal and it progresses with
age; however, it rarely develops into a disease that threatens the blood supply (Subbotin,
2007).
Studies have shown that stenosis at the anastomosis of autologous and allogenic
vascular grafts caused by IH may be initiated by hemodynamic changes that occur near
the anastomosis (Haruguchi, 2003; Kohler, 1992; Keynton, 1995). With end-to-side
anastomoses, IH tends to develop at the arterial floor and the toe and heel of the distal
anastomosis (Haruguchi, 2003; Keynton, 1995). Low shear stress and oscillating shear
index are hemodynamic factors that correlate with IH formation on the floor (Haruguchi,
2003; Keynton, 2001).
It has also been theorized that intimal thickening is a physiological adaptation to
changing hemodynamic demands (Subbotin, 2007). Asakura et al. confirmed the “slowflow” effects on the development of IH by performing experiments on transparent arterial
models, which maintained the true arterial geometry, where slow or disturbed flows were
found to be associated with severe hyperplasia (Asakura, 1990). In vivo experiments
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using arterial bypass grafts in a dog model found that low shear stress and oscillating wall
shear seem to provide a stimulus for the development of IH near the anastomosis
(Keynton, 2001). It has been well-documented that aging also alters hemodynamic
parameters. In regards to this fact, Osika et al. (2007) found in measurements the intima
and intima-media thicknesses in radial and anterior tibial arteries increase with aging. In
addition, the anterior tibial artery showed thicker intima and a thinner media compared to
the radial artery, especially in the older subjects. In order to consider the different
luminal diameters between the two arteries, the authors compared the intima thickness
(IT) to lumen ratio and found a significant difference across all age groups investigated
(ages 10-90 years) (Osika, 2007). These results may be due to the postulated “slowflow” effects that Asakura and Keynton, et al. investigated since the blood velocity in the
anterior tibial artery is much lower than in the radial artery.

2.4 Current methods to assess arterial patency
Physicians utilize brachial indices, CT, and MR angiography to assess the
performance of the grafts in hand transplant patients on a regular basis. Ultrasound is
used to obtain segmental pressure measurements of arm and digital arteries. From these
measurements, physicians use brachial indices to evaluate vascular perfusion of the hand
and digits in several conditions such as rheumatoid arthritis, systemic lupus, Berger’s
disease, atherosclerosis, trauma, and hand transplantation. In each of these conditions,
vascular supply is decreased. For hand transplants, digital brachial indices are used to
eliminate the suspicion of any obstructive phenomena which could compromise
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perfusion. This could include an anastomosis site with developing constriction or
advanced intimal hyperplasia.
A digital brachial index is obtained by calculating the ratio of the specified digital
blood pressure to the simultaneous brachial artery pressure. Typically, brachial indices
are also calculated for the ulnar, radial, and palmar arch arteries. Without sufficient
blood flow to the artery, the surrounding tissues will not receive the oxygen and the
proper nutrients needed to stay viable. In a hand transplant patient, an inadequate blood
supply to the graft will lead to ischemia and eventually to rejection of the transplanted
hand. Clinical practice regards brachial indices of 0.7 or less as an indication of
inadequate blood flow to the particular artery. Conversely, a digital brachial index above
0.7 is indicative of adequate blood flow (Zimmerman, 1994). It is unclear why the
clinically-accepted threshold has been set to 0.7; however, it was likely influenced by the
study of Gelberman et al. (1978) and Gross et al. (1978). Gelberman studied a group of
patients with replanted digits, and observed that all patients with a digital pulse pressure
that was less than 75% of the contralateral side suffered from severe cold intolerance
(Gelberman, 1978). While Gross et al. reported that patients with a segmental pressure of
63% or less on the contralateral side suffered from forearm claudication (Gross, 1978).
Zimmerman et al. (1994) used 0.7 as a midway between these two studies to guide their
choice between ligation or reconstruction of the ulnar artery in patients with ulnar artery
occlusion.
MR and CT angiography are non-invasive imaging techniques that provide a
visualization of the arterial tree. They allow an assessment of patency. However, the
resolution of these imaging techniques is not sufficient to detect the arteriopathy that is
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present in hand transplant patients, including dangerous levels of IH. Thus, the efficiency
and accuracy of these techniques for evaluation of hand transplant is questioned.
These techniques are used to evaluate the performance of transplanted hands. If a
clinician discovers signs of rejection from any of these methods, he may choose to alter
immunosuppression in order to halt the progress of chronic rejection. Despite these
methods, the fourth hand transplant recipient in the Louisville CTA program lost his graft
nine months after transplantation from ischemia due to severe graft arteriopathy. The
transplant procedure performed in the Louisville CTA Program occurred in July 2008 and
consisted of a short, transradial right hand transplant. The patient’s post-operative
therapeutic regimen consisted of an immunosuppression induction treatment (Campath
1H) which was designed to need only two types of immunosuppression. The patient was
never started on steroids and was maintained on a double therapy of tacrolimus and
mycophenolate mofetil (MMF). Nine months post-transplantation, this patient had
unmanageable ischemia in the hand which developed over a few weeks. After failed
attempts to surgically restore blood flow, the decision was made to amputate.
Histological analysis of tissue from the amputated graft indicated that ischemia
was secondary to severe chronic rejection, which manifested as massive intimal
hyperplasia that restricted the arteries of the allograft. The intimal hyperplasia was so
severe that the lumen was miniscule. In addition, some histological slices showed
thrombus formation (Figure 1 and 2). This was the first report of chronic rejection in a
compliant CTA hand recipient.
Conventional imaging techniques and clinical measurements, including CT and
MR angiography and measurements of digital brachial indices via ultrasound, did not
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indicate the severity of the patient’s condition. Specifically, the CT angiography
measurements acquired at the patient’s home hospital indicated patent vessels with the
only stenosis noted (judged to be 50%) being at the anastomosic site. Similarly, a few
days before amputation of the graft, the patient’s transplant (right hand) radial and ulnar
arteries at the wrist had brachial indices of 0.76 and 0.70, respectively, while his native
(left hand) radial and ulnar arteries at the wrist had brachial indices of 1.03 and 1.04,
respectively. With these values, this patient was considered to be at or near border line
since a value below 0.70 is clinically regarded as a compromise of perfusion. Analysis of
punch skin biopsies two days before the graft was amputated had a histology grade of 0,
which was interpreted as no rejection (Cendales, 2007). It is important to note that the
vessels investigated were not pressurized prior to histological fixation. Thus, the
resulting images may provide an inaccurate indication of the severity. However, the
vessels were occluded enough to warrant amputation.

FIGURE 1 – Histological slide of donor radial artery taken at CTA graft amputation.
Severe intimal hyperplasia, thrombus, and near occlusion of the lumen were noted.
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FIGURE 2 – Histological slide of donor ulnar artery taken at CTA graft amputation.
Severe intimal hyperplasia and near occlusion of the lumen were noted.
After the loss of the graft in the fourth Louisville CTA patient, the remaining four
transplant patients were brought back to Louisville to look for evidence of arteriopathy
and/or chronic rejection. Conventional vascular studies and punch skin biopsies of the
remaining patients did not show any evidence of chronic rejection. However, deep
biopsies revealed minimal to moderate arteriopathy in each of the four patients, who had
no other serious indications of graft rejection. In particular, each patient revealed intimal
hyperplasia. Thus, vessel wall thickening of the arterial tree should be examined closely
in CTA recipients as the arterial tree may be a target of chronic rejection. The hand
transplant patients that still have viable grafts have intima thicknesses between one cell
layer thick (approximately 8µm) to 0.26 mm. Measuring these very small layers has not
been possible without a biopsy accompanied with a histological examination.
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2.5 Ultrasound Biomicroscopy
Until recently, only post-mortem methods of IH assessment were available via
histology. However, histological preparation causes tissue shrinkage, which can
significantly alter the measurement of luminal diameter changes (Razevaev, 2008). In
addition, a real-time, noninvasive method is highly desirable for clinical applications to
monitor the progression of vascular wall changes which impact the outcome of several
diseases, including arteriosclerosis and chronic rejection. Originally developed for small
animal applications, a very high resolution ultrasound system, called ultrasound
biomicroscopy (UBM), was implemented to non-invasively detect in vivo structures as
small as 30 µm.
Recently, UBM has been used in clinical studies for machine validation purposes
as well as for detecting changes in the arterial walls. Razuvaev et al. (2008)
demonstrated the possibility of using UBM to measure the intimal thickness in the rat
carotid artery after balloon injury and to monitor the formation and progression of intimal
hyperplasia during pharmacological treatment. Their UBM measurements of the intimamedia thickness in left and right common carotid artery of 15 rats correlated significantly
with histological measurements (p < 0.0001). They also discovered that as intima-media
thicknesses increased over time, lumen diameters decreased. The use of UBM to
measure lumen diameter in vivo and in real time provides a new way to study arterial
remodeling and vessel responses to flow changes in the arterial vessel wall (Razuevaev,
2008).
Osika et al. (2007) utilized UBM to determine the thickness of artificial layers of
silicone and intima thickness (IT) of radial and anterior tibial arterires in healthy subjects
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and in patients with vascular disease. They found that IT and the IT-to-lumen ratio
progresses with age. The anterior tibial artery exhibited thicker intima and thinner media
thicknesses than the radial artery. In addition, the radial artery IT in patients with
peripheral artery disease was thicker compared with the healthy controls. As a validation
experiment and to assess UBM resolution, Osika et al. (2007) imaged silicone layer
phantoms at a transducer frequency of 55 MHz. These measurements were compared to
the gold standard method of measurement by weighing. They obtained a correlation
coefficient of 0.98 and found a mean difference and standard deviation as low of 3.5 ±
8.8 µm, illustrating the high accuracy associated with UBM (Osika, 2007).
Johansson et al. (2010) used the high resolution ultrasound to compare healthy
subjects to those with end-stage renal disease (ESRD). They found that the IT, intimamedia thickness (IMT), and media thickness (MT) of the radial artery were all
significantly higher in ESRD patients compared to healthy subjects (p<0.05). They also
discovered that ESRD patients had significantly higher IT to lumen diameter ratios that
healthy subjects (p<0.01). The authors speculate that this may reflect global
atherosclerosis (Johansson, 2010).

2.6 Summary
The signs and symptoms of acute and chronic rejection have been presented. The
hallmark characteristic of chronic rejection, intimal hyperplasia, is a major concern for
the Louisville CTA program. Current diagnostic techniques are unable to non-invasively
image or measure the intimal layer thickness of the arterial wall. Only post-mortem
methods of assessing IH thickness are available via histology. Recently, a very high
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resolution ultrasound system, called ultrasound biomicroscopy (UBM), has been
implemented to non-invasively detect in vivo structures as small as 30 µm. It provides an
accurate, real-time, and non-invasive method to image the arteriopathy present in hand
transplant patients.
The hand transplant clinicians at the Louisville CTA program had several
questions in relation to the rejection of their fourth patient. First, they asked how this
severe intimal hyperplasia manifested. They wondered if it could be induced
mechanically (i.e. applying forces repetitively to the arm) or from the lower
immunosuppressive regimen that was administered to this patient. Secondly, they needed
a more reliable way of visualizing the transplant arteries to check for and monitor any
signs of severe intimal hyperplasia or stenosis. Ideally, this method would avoid the
morbidity and impracticality of multiple deep tissue biopsies. Finally, it is unknown
what level of intimal hyperplasia would warrant a change in immunosuppression therapy
in order to protect the graft from ischemia. Thus, identification or development of a new,
non-invasive, high-resolution imaging technique capable of monitoring the progression of
IH in CTA graft patients would enable clinicians to appropriately address these questions.
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III. INSTRUMENTATION AND EQUIPMENT
The following section contains information about instrumentation and equipment
used in the completion of this thesis.

3.1 Digital brachial indices instrumentation
A Flo-Lab 2100-SX (Parks Medical Electronics, Aloha, OR) was used to obtain
the pulse pressures in the arteries of both arms (Figure 3). The Flo-Lab system consisted
of cuff inflators, Doppler probes, photoplethysmography (PPG) sensors, and a monitor
for real-time readings. From there, the digital brachial indices were calculated. Several
inflatable cuffs accompanied the machine. Large cuffs were used to find pulse pressures
in the upper arm. Medium and small cuffs were used on the forearm and wrist,
respectively, while very small cuffs were used to determine pulse pressure in the digits.
Each cuff had a maximum pressure of 300 mmHg. A Doppler pencil probe operating at a
continuous wave frequency of 8 MHz employs sound waves and sonar detection to detect
the moment when blood flow returns as the cuff is deflating. Then, it is able to gather the
pressure measurement and generate pressure waveforms for each artery, except the digital
arteries. The pressure waveforms were used to gather pressure measurements of each
artery. From the pressure measurements, the brachial indices were calculated. A
photoplethysmography (PPG) sensor was used in the place of the Doppler probe for the
digital arteries to acquire pressure data from the digital arteries by determining the
moment when blood flow returns to the cuff.
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FIGURE 3 -- Flo-Lab 2100-SX for brachial index measurements

3.2 Ultrasound Biomicroscopy Instrumentation
The native and transplanted arteries were examined by Ultrasound Biomicroscopy
(UBM; Vevo 2100, VisualSonics, Toronto, Canada) using multiple transducers with
varying frequencies. Transducer selection was based on depth of the vessel to be imaged
in combination with image resolution to acquire optimum intimal hyperplasia
measurements. The axial image resolution ranged from 30 µm to 75 µm. The mainframe
used a 120V, 50/60Hz AC power supply.
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Monitor

Controls

Transducer

FIGURE 4 – The Vevo 2100 ultrasound biomicroscopy system.

3.2.1 Transducers
Five different transducers (MS-250, MS-400, MS-550D, MS-550S and MS-700;
VisualSonics, Toronto, Canada) were used to acquire images along a line perpendicular
to the vessel wall. The following table lists their center frequency, broadband frequency,
geometric focus, maximum image width, maximum image depth, image axial resolution,
and image lateral resolution. The resolutions were quoted at the geometric focus.
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TABLE I
VEVO 2100 TRANSDUCER CHARACTERISTICS
Transducer Name
Center Frequency (MHz)
Broadband Frequency (MHz)
Geometric Focus (mm)
Max Image Width (mm)
Max Image Depth (mm)
Image Axial Resolution (µm)
Image Lateral Resolution (µm)

MS-250
20
13-24
15
23.1
36
75
165

MS-400
30
18-38
9
15.4
20
50
110

MS-550D
40
22-55
7
14.1
15
40
80

MS-550S
40
32-56
6
15.1
15
40
80

MS-700
50
30-70
5
9.7
TBD
30
65

3.3 Sphygmomanometer and Stethoscope
The blood pressure of each subject was measured before and after UBM
examination. The blood pressure measurements were obtained using a Moore Medical
775-660 (New Britain, CT) professional aneroid sphygmomanometer and stethoscope
(Figure 5). The sphygmomanometer had a maximum range of 300 mmHg and was
accurate to +3mmHg.

FIGURE 5 -- Moore Medical 775-660 sphygmomanometer and stethoscope
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3.4 Pulse Oximeter
At the time of UBM examination, oxygen saturation measurements were acquired
simultaneously. The saturation of peripheral oxygen (S p O 2 ) was measured in the second,
third and fourth digital arteries of both the native and transplant hands for each subject
with a Nonin Onyx 9500 Fingertip Pulse Oximeter (Plymouth, MN). The Nonin Onyx
9500 pulse oximeter has an oxygen saturation declared accuracy range of 70-100% SpO 2
±2 digits and a range of 0-100% SpO 2 .

FIGURE 6 -- Nonin Onyx 9500 pulse oximeter

3.5 Data processing
Processing of data from the UBM as well as statistical analysis was performed on
a Lenovo Y430 laptop (Lenovo, Morrisville, NC). From the manufacturer of the UBM
machine, the Vevo 2100 1.1.0 (VisualSonics, Toronto, Canada) software was used to
make measurements and collect still images from the UBM data. Microsoft Excel 2007
was used for tabulation of data and calculations. Statistical analyses were performed
using Minitab 15 software (Minitab, State College, PA).
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IV. PROCEDURE
Please note section 4.1 includes information about the transplantation procedures
and details for each patient. Sections 4.1 and 4.2 were not performed by the author of
this paper, and are included in this presentation for a more clear understanding of the
research to the reader.

4.1 Hand transplantation patient profiles
Deceased donors had to meet several inclusion criteria before being used for the
composite tissue allotransplant (CTA). Donors had to meet the standard criteria for
determination of brain death and donation after cardiac death was not considered. An
ABO blood type group compatibility and a positive/negative blood type cross-match was
required. Based on the preferences of the recipient and the judgment of the transplant
team, matching for sex, skin tone, race, and age were sought. Donors were not included
if they had active infection (HIV, hepatitis B and C, viral encephalitis), malignancy,
current intravenous drug use, inherited or metabolic neuropathy, and rheumatoid or
osteoarthritis. Detailed evaluations of the limbs of potential donors were performed,
including range of motion in all joints, evidence of trauma/arthritis, and X-rays.
For limb procurement, a circumferential incision was made around the arm with
identification of the underlying veins and nerves. A longitudinal incision was made
along the medial arm over the brachial vessels to enable cannulation for cold perfusion of
the limb. The limb was cooled externally by topical application of sterile saline slush and
internally by perfusion of the brachial artery with University of Wisconsin solution
(ViaSpan, Dupont Merck Pharmaceuticals, Wilmington, DE) at 4°C. The resected arm
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was then wrapped in moist sponges and placed in a sterile container for transportation.
For the transplantation procedure, the sequence of tissue repair was in the following
order: bony fixation, arterial revascularization, vein repair, tendon repair, and nerve
repair.
Brief patient histories including vascular repair descriptions, immunosuppression
regimens, and adverse events are provided below for each subject investigated in this
report.
Patient 1
Patient 1 received a transplantation of the left hand and forearm in January 1999.
Vascular repair was carried out by and end-to-end anastomosis of the donor radial artery
to the recipient radial artery, and donor ulnar artery to the recipient ulnar artery. The
patient received the standard immunosuppression regimen of triple drug therapy.
Specifically, patient 1 was treated with a combination of tacrolimus, mycophenolate
mofetil (MMF), and prednisone. To reduce side effects from the drug therapy, patient 1
was weaned-off of the steroid (prednisone) 8 years after transplant.
Patient 1 had three episodes of acute rejection in the first year after
transplantation, which were easily controlled with short courses of additional medication,
generally steroids. The patient developed a viral infection common to transplant patients,
cytomegalovirus (CMV), at three months after transplant that responded to medication.
For patient 1, motor function improved from the end of the first year to six years and has
remained relatively stable. The patient continues to experience sensory changes, even at
11 years post-transplant.
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Patient 2
Patient 2 received a transplantation of the right hand and forearm in November
2006. Vascular repair was carried out by an end-to-end anastomosis of the donor radial
and ulnar arteries to the recipient radial and ulnar arteries. There was a vein graft used
from the recipient on the donor ulnar artery because the ulnar vessel was not long
enough. The same may also apply to the radial artery. Patient 2 received an
immunosuppression induction treatment (Campath 1H) that was designed to need only
two types of immunosuppression. The patient was never started on steroids, but was
maintained on tacrolimus and MMF. Patient 2 was the first hand transplant patient to
have successfully avoided prednisone maintenance. However, patient 2 was suspected to
have marginal zone lymphoma, since an unusual B-cell clone and a monoclonal T-cell
clone was identified in his blood at 23 months post- transplant.
Patient 2 had three significant rejection episodes in the two years following his
transplant. The first episode was a period of combine rejection and infection (CMV) at
two months post transplant. The third episode of rejection was in response to decreasing
immunosuppression, and was resolved once immunosuppression was restored.
Patient 3
Patient 3 received a transplantation of the right hand and forearm in November
2008. Vascular repair was carried out by end-to-side anastomoses of the donor radial and
ulnar arteries to the recipient’s brachial artery, just proximal to the antecubital fossa.
Patient 3 also received the Campath 1H immunosuppression and was maintained on
tacrolimus and MMF, before adding prednisone to his immunosuppression a few months
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after transplantation. The patient was started on prednisone after the amputation of the
graft in the fourth Louisville CTA transplant recipient.
Patient 4
Patient 4 received transplantation of the left hand and forearm in February 2001.
The patient received a similar immunosuppression regimen as the first patient, with the
triple drug therapy of tacrolimus, MMF, and prednisone as well as Simulect as an
induction agent. Simulect is an antibody to the IL-2R. However, this patient developed
high blood sugars that were difficult to control due to the high levels of tacrolimus and
the multiple steroid bolus regimens used to treat rejection in the weeks following
transplantation. To improve the patient’s blood sugar levels, MMF was discontinued and
switched to another type of immunosuppressant, rapamycin. Late in the post-transplant
course, this patient was successfully weaned-off the steroids and has been maintained on
tacrolimus and rapamycin.
It may be important to note that part of the patient’s native arm was also injured in
the explosion that caused the loss of the left hand. Patient 4 had some scaring on the
native arm on the ulnar side. In addition, at the time of the UBM examination, the patient
had a rash on the transplant palm and wrist. The clinicians indicated that this could be a
sign of rejection or it could be a dermatological reaction. The rash was only on the
transplanted hand and the clinicians claim that the transplant hand is more susceptible to
dermatologic reactions. In addition, patient 4 used both hands in manual labor related to
the patient’s business and both hands had several calluses. These calluses appeared to
impact the UBM visualization of the blood vessels subcutaneously by increasing the
reflection of the acoustic beams through the tissue.
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This patient had five episodes of acute rejection in the first year that responded to
short courses of increased medication. In the fifth and seventh year post-transplant, the
patient had another rejection episode related to non-compliance with medication. This
patient also developed osteonecrosis of both hips (one side in year 2 and one side in year
6 after transplantation), which required total hip replacement on both sides. This was
directly related to the immunosuppressive regimen (prednisone and/or tacrolimus). The
hand transplant team addressed this issue by implementing a steroid sparing induction
regimen using Campath 1H in the subsequent patients, which has been routinely used in
kidney transplantation.

4.2 Ultrasound for obtaining digital brachial indices
The systolic pressures of the brachial artery at the upper arm, the radial artery at
the wrist, the ulnar artery at the wrist, and each digital artery around the proximal phalanx
were determined at least once a year using a Flo-Lab 2100-SX (Parks Medical
Electronics, Aloha, OR). In addition, the artery with the greatest pressure at the wrist
(either the ulnar or radial) was used to determine the systolic pressure in the forearm.
A certified ultrasound technician performed the exams. Ultrasonic gel was used
on the skin of the patient where the ultrasound was obtained. The cuffs were placed on
both arms and a Doppler pencil probe operating at a continuous wave frequency of 8
MHz was used to isolate the artery of choice (except in the digital arteries). The pressure
cuffs were inflated until the pressure waveform became a flat line. Next, the cuff
pressure was decreased until the waveform reappeared. The technician used manual
controls to determine when the pressure waveform first reappeared by moving a cursor to
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this location. This pressure value was then recorded. For the digital arteries, a much
smaller cuff was used in combination with the PPG sensor, in place of the Doppler pencil
probe. The brachial indices were calculated as the ratio of the systolic pressure at the
specified artery over the systolic pressure of the brachial artery of the native arm. Thus,
the brachial indices are normalized to the native arm.

4.3 Ultrasound Biomicroscopy
Ultrasonic gel was put on the patients’ skin where the ultrasound was to be
acquired. Each patient’s arm was examined by UBM using a transducer. The frequency
of the transducer was chosen based upon the depth of the artery being examined. When
examining radial and ulnar arteries, a 30 or 40 MHz transducer was generally chosen to
obtain an image. If the artery was deeper, a lower frequency transducer was used. If the
artery was more superficial, a higher frequency transducer was chosen to maximize
resolution while balancing the limitations of penetration depth. The following arteries
were examined in each patient:
TABLE II
ARTERIES EXAMINED
Arm

Transplant

Artery
Brachial
Ulnar
Radial
Palmar arch
Digit 1
Digit 2
Digit 3
Digit 4
Digit 5
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Native

Brachial
Ulnar
Radial
Palmar arch
Digit 1
Digit 2
Digit 3
Digit 4
Digit 5

Images of each arterial region of interest were acquired with a linear array
transducer connected to Vevo 2100 ultrasound biomicroscopy (VisualSonics, Toronto,
Canada). The resolution, frame rate and maximum tissue penetration of each transducer
may be found in the previous Instrumentation and Equipment section. A cine loop, for a
minimum of 4 seconds and maximum of 5 seconds, was acquired from each artery. All
images were analyzed using the image analysis software, Vevo 2100 1.1.0, provided by
Vevo 2100. Figure 7 shows an image taken from the cine loop of the radial artery of a
transplanted arm.
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FIGURE 7 – Ultrasound image acquired by the UBM for a radial artery from a
transplanted arm.

Subjects were examined sitting down with the arm being examined resting on a
table. The brachial artery was examined proximal to the antecubital fossa. The ulnar and
radial arteries were measured between 1 and 2 cm proximal to the skinfold separating the
palma manus (palmar region of the hand) from regio antebrachii anterior (anterior region
of the forearm) at the position of the thickest part of the far wall (visually judged). The
cine loop was examined in a longitudinal projection. Data analyses were completed after
patient examination using the Vevo 2100 software loaded on the Lenovo Y430 laptop
computer.

4.4 Arterial Measurements
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Three measurements of the intima thickness (IT), intima-media thickness (IMT),
and lumen diameter (LD) were performed during systole, that is, when the artery
exhibited its largest diameter. IT was defined as the distance from the leading edge of the
lumen-intima interface to the intima-media interface of the far wall. IMT was defined as
the distance from the lumen-intima interface of the far wall to the leading edge of the
media-adventitia interface. Lumen diameter was defined as the distance between the
leading edges of the intima-lumen interface of the near wall and the lumen-intima
interface of the far wall. The media thickness (MT) was determined by subtracting the IT
from the IMT. These methods have been previously described by Wendelhag et al.
(1991) and implemented in other vascular ultrasound studies as well (Johansson, 2010;
Razuvaev, 2008; Osika, 2006). Figure 8 illustrates the definition of lumen, intima, and
media from a UBM image of a transplanted radial artery.

Lumen
Intima
Media

FIGURE 8 – Image defining the lumen, intima, and media layers extracted from an UBM
image.
The arterial diameters varied between subjects and region of investigation. Some
patients may have larger intima thicknesses than others, but they might also have larger
lumen diameters. If both their lumen and intima thicknesses were larger, the level of
intima in one patient may not be as severe in another patient with a smaller lumen. Thus,
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three ratios were calculated to create normalized variables for comparison across the
subjects: IT/LD, IMT/LD, and MT/LD. Normalizing the measurements addresses the
variability between different patients. All of these measurements were compared to the
brachial indices as well, since brachial indices are the most commonly used method to
assess arteriopathy in these patients.

4.5 Hoop stress calculation
In order to better understand the mechanical factors involved with the intimal
hyperplasia of hand transplant patients, hoop stress was calculated for each vessel. Hoop
stress is the amount of stress which occurs in the circumferential direction in a thinwalled vessel. The hoop stress is defined by the following equation:

In this study, calculations of the hoop stress of the arterial walls were performed using
data from the pressure measurements obtained with the Flo-Lab 2100 and arterial
dimensions acquired by the UBM.

Specifically, the variables in the equation are:

p=pressure in the artery (mmHg), D=lumen diameter (mm), and t=wall thickness of the
artery. The pressure values used were obtained from the ultrasound to obtain the brachial
indices. The lumen diameter values used were the LD measurements from the UBM
examination. Lastly, the wall thickness was identified as the intima-media thickness
(IMT), which was also obtained from the UBM examination.

4.6 Blood pressure measurement
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A registered nurse took blood pressure measurements of each patient before and
after the UBM examination using a professional aneroid sphygmomantometer and
stethoscope. Patients sat upright in a chair, resting their arms on a table. Blood pressure
measurements were read aloud and noted.

4.7 Oxygen saturation measurement
Oxygen saturation of the second, third, and fourth digits on each hand for each
patient was measured using a pulse oximeter before the UBM examination. As with the
blood pressure measurements, patients sat in a chair, resting their arms on a table.
Oxygen saturation percentages were read aloud and noted.

4.8 Statistical Analysis
Because of the small samples size available, demonstrating normal distribution of
the data is difficult. Thus, the nonparametric equivalent of a one-way analysis of
variance (ANOVA), the Kruskall-Wallis test, was used to determine statistical
significance, defined as p<0.05. Data was copied from Microsoft Excel 2007 into
Minitab 15. Within Minitab, averages of parameters from the transplanted and native
hands were calculated. Then, the Kruskall-Wallis test was performed in Minitab to
determine significance. Comparisons were made using the Pearson correlation
coefficient.
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V. RESULTS AND DISCUSSION OF RESULTS
5.1 Brachial index measurements
A goal of this project was to compare the relationships that existed between
brachial indices and transplanted arteries versus native arteries. Defined as the pressure
ratio from the indicated artery to the brachial artery, the use of the brachial index to
assess perfusion in hand transplant patients is questioned. Clinical practice regards
brachial indices of 0.7 or less as an indication of inadequate blood flow to the indicated
artery. The first patient examined, who has had their graft for 11 years, was the only
patient to have at least one brachial index below the 0.7 threshold. Overall, the brachial
indices of this patient’s transplanted arm were much lower than his native arm (Table
III). For example, the average difference between brachial indices of transplanted artery
versus the native artery on the contralateral arm was 0.11. This large difference between
arms suggests that the patient’s transplanted arm is not being perfused as well as their
native arm. However, this data does not provide a clear indication of whether the patient
has a significant level of arteriopathy that warrants a change in immunosuppression in
order to protect the graft from ischemia. In addition, this patient’s digital brachial indices
ranged from 0.69 (digit 5) to 0.81 (digit 3), with an average value of 0.75. Even though
some of the brachial indices fell below the prescribed threshold value, the clinicians
decided not to change his immunosuppression.
Patient 2, at 3 years post-transplant, had just slightly lower brachial indices in his
transplanted arm, with an average difference of 0.06. His lowest index was with digit 2
being 0.77. Patients 3 and 4 had much higher brachial indices on both the transplanted
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and native arms than the first two patients. Patient 3, at 15 months post-transplant, had a
lowest brachial index of 0.89 in the transplanted digit 5. Patient 4, at 9 years posttransplant, had a lowest brachial index of 1.10 in the transplanted digit 1. Thus, from a
clinical viewpoint, patients 3 and 4 showed no sign of compromised blood flow, which
could be caused by an obstructive phenomenon such as intimal hyperplasia. However,
though patients 3 and 4 had the highest brachial indices, they exhibited the largest
differences between arms.
A Kruskal-Wallis, nonparametric statistical analysis, was performed on the data to
determine if the condition of being a transplanted artery significantly affected the brachial
index value. An analysis was performed using each patient separately and another
analysis was performed using the data from all four patients together. From the data
analyzing each patient separately, only patients 3 and 4 were found to have significantly
(p=0.007 and p=0.022, respectively) lower brachial indices in their transplanted hand and
forearm. This was a bit surprising, considering these patients were also found to have the
highest brachial indices. Although patient 1 was close to statistical significance, the pvalue of 0.064 did not meet our statistical significance cut-off criteria of p = 0.05. From
the statistical analysis using the data from all four patients together, the transplanted arm
was found to have significantly (p=0.037) lower brachial indices than in the contralateral
arm.
From a clinical perspective, these results suggest that the arteries of the
transplanted hand do not have the same level vascular perfusion as the native arm.
Currently, clinicians used brachial indices to eliminate the suspicion of any obstructive
phenomenon which could compromise blood flow, such as intimal hyperplasia.
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However, these results do not provide useful information regarding the presence and
level of arteriopathy found in those arteries. The author has been unable to find studies
that included brachial index measurement besides the very limited data in the papers that
establish the clinical threshold of 0.7.
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TABLE III
BRACHIAL INDEX RESULTS

Subject
1
2
3
4
Average

Subject
1
2
3
4
Average

Ulnar
0.99
0.93
1.05
1.25
1.055 ± 0.139

Ulnar
1.10
0.99
1.11
1.39
1.148 ± 0.171

Radial
0.97
0.88
1.05
1.23
1.033 ± 0.149

Radial
1.01
1.14
1.15
1.48
1.195 ± 0.2

Palmar Arch

Palmar Arch

Transplant Brachial Index
Digit 1
Digit 2
0.79
0.76
0.80
0.77
1.02
0.96
1.10
1.18
0.928 ± 0.156 0.918 ± 0.198

Digit 3
0.81
0.78
1.09
1.27
0.988 ± 0.234

Digit 4
0.72
0.81
0.93
1.19
0.913 ± 0.204

Digit 5
0.69
0.81
0.89
1.22
0.903 ± 0.227

Native Brachial Index
Digit 1
Digit 2
0.80
0.92
0.80
0.75
1.11
1.19
1.22
1.50
0.983 ± 0.215
1.09 ± 0.328

Digit 3
0.97
0.80
1.02
1.30
1.023 ± 0.208

Digit 4
0.89
0.88
1.50
1.46
1.183 ± 0.344

Digit 5
0.92
0.91
1.16
1.24
1.058 ± 0.168

Note: The Palmar Arch column was intentionally left blank.
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5.2 Ultrasound Biomicroscopy measurements
For the first time in clinical history, a clinical tool has become available to now
enable clinicians to monitor the thickening of the arterial wall over time. The UBM has
provided a way to non-invasively and accurately measure the same area over time with
real-time results. This will give the clinician valuable information regarding the
progression of chronic rejection. Unlike acute rejection, chronic rejection does not come
in episodes. It is a single, progressive event that can take several months (as with the
recipient who lost their graft at the Louisville CTA Program) or several years to manifest
into a threat to the viability of the transplant. Using the protocol described here, effects
of particular treatments and conditions (i.e. changing immunosuppression treatments,
mechanical factors, etc.) may be investigated to understand their effects on chronic
rejection.
In total, 255 cine loops were collected with the UBM in this study. Each cine
loop includes 100 image frames. Only a portion of the cine loops were used for analysis.
This was for many reasons: the image would blur once it had started recording the cine
loop, the operator trying to obtain a better image, or the clinicians finding anomalies
unrelated to this project that they wanted to record. A total of 59 images were analyzed.
Nine measurements were taken in each image: 3 intima, 3 intima-media, and 3 lumen
diameter. Thus, there were a total of 531 raw measurements of the UBM data.

5.2.1 Intima Thickness
One hypothesis of the project was that the intima thicknesses are significantly
larger in the transplanted hand than in the native hand. In each patient the radial and
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ulnar arteries, palmar arch, and each of the five digital arteries were examined using the
UBM. However, in patients 1 and 3, not every artery was examined due, for the most
part, to inherent limitations of the ultrasound system. In particular, with ultrasound
transducers, there is a compromise between frequency (and, therefore, resolution) and
acoustic depth of penetration, where the depth of penetration is inversely proportional to
the operating frequency of the ultrasound transducer as seen in the following equation:

Where Z max is penetration depth, v max is the maximum velocity, c is the speed of sound,
and f o is the operating frequency. Assuming the maximum velocity is constant, it is seen
that as the frequency is increased, the depth of penetration or range of the acoustic beam
is decreased.
Since some patients had much larger arms than others, the depth of penetration
increased for the ultrasound to travel in order to image the arteries of interest.

Since

some patients had swelling, inflammation or scarring of the hand, the depth of
penetration for imaging the arteries of interest dramatically increased, which directly
influenced the ability to acquire an adequate image. In addition, if the patient had
swelling or inflammation of the hand, this also increased the depth of penetration
dramatically. Another potential cause for the inability to acquire data in some arterial
vessels was the UBM operator having difficulty locating the digital arteries. The arterial
anatomy of the hand is complex and highly variable from person-to-person.
Maneuvering the transducer around the digits also introduced issues, especially since
ultrasound has difficulty penetrating bone. Much of the volume of the digits is composed
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of bone. The physical size of the transducer was sometimes too large to acquire a clear
image of the digital arteries, since the edges of the transducer would extend over the
finger.
The smallest intima thickness (Table IV) found was 0.052 mm in the native
second digital artery of patient 1. The largest intima thickness found was 0.177 mm in
the transplanted radial artery of patient 2. The intima in almost all arteries was larger in
the transplanted hand compared to the native hand. As with the brachial index, a
Kruskal-Wallis test was used to determine if the intima of the arteries in the transplanted
hand were significantly larger than the intima of the arteries in the native hand. From the
statistical analysis using the combined data from all four of the patients, the transplanted
hand was found to have significantly (p=0.001) larger intima thicknesses than the native
hand. Thus, the first hypothesis is accepted: the intima thicknesses are significantly
higher in the transplanted hand, using the patient as his own control.
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TABLE IV
INTIMA THICKNESS RESULTS

Subject
1
2
3
4
Average

Ulnar
0.152
0.122
0.121
0.14
0.134 ± 0.015

Radial
0.119
0.177
0.121
0.145
0.141 ± 0.027

Subject
1
2
3
4
Average

Ulnar
0.090
0.084
0.109
0.100
0.096 ± 0.011

Radial
0.090
0.108
0.117
0.120
0.109 ± 0.013

Palmar Arch
0.094
0.108
0.12
0.107 ± 0.013

Palmar Arch
0.099
0.090
0.120
0.103 ± 0.015

Transplant IT (mm)
Digit 1
Digit 2
0.090
0.090
0.102
0.094 ± 0.007

Digit 3
0.074
0.103
0.074
0.091
0.086 ± 0.014

Digit 4
0.100
0.096
0.079
0.102
0.094 ± 0.01

Digit 5
0.095
0.105
0.084
0.132
0.104 ± 0.021

Native IT (mm)
Digit 1
Digit 2
0.084
0.052
0.072
0.054
0.064
0.070
0.054
0.084
0.069 ± 0.013 0.065 ± 0.015

Digit 3
0.102
0.060
0.063
0.066
0.073 ± 0.02

Digit 4
0.079
0.066
0.077
0.067
0.072 ± 0.007

Digit 5
0.085
0.090
0.070
0.060
0.076 ± 0.014

0.060
0.066
0.063 ± 0.004
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Small levels of intimal hyperplasia have been found to be normal, which
progresses with age (Subbotin, 2007; Osika, 2007). The defining feature of chronic
rejection has been defined as the progressive thickening of the arterial walls within the
affected organ due to intimal hyperplasia (Geraghty, 1996; Merville, 2005; Hayry, 1991;
Ross, 1993). The results of this investigation indicated that the intima of the arteries in
the transplanted hand were larger than in the native hand by an average of 0.022 mm.
Nonetheless, no UBM image from the patients involved in this study suggested that the
thickening was so severe as to threaten the vascular supply to the hand.
This is the first known study that compares IH between native and transplanted
hands. The increased IH likely indicates early signs of chronic rejection in each of the
patient. The levels of IH found do not seem to threaten the viability of any of the
transplants in the near future. However, it is crucial that the clinicians monitor the
progression of IH in these patients. It is not clear what level of IH would warrant
increases in immunosuppression, but the UBM provides a real-time image of the arterial
cross-section. From there, the physician can make a clinical decision as to whether or not
extra measures should be taken. In addition, it is vital that the patients adhere to their
immunosuppression. If they did not take their immunosuppression, the IH would grow
much more rapidly.

5.2.2 Intima-media and media thicknesses
Using a Kruskal-Wallis test, it was found that the IMT of the transplanted hand
was not significantly larger than in the native hand. The average IMT (Table V) for the
transplanted hand was 0.204 mm, while the native hand had an average IMT of 0.187
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mm. The effect of chronic rejection is seen in the intima layers of arteries (Geraghty,
1996; Merville, 2005; Hayry, 1991; Ross, 1993). Since the media makes up the bulk of
the arterial wall (Shier, 2006), it is logical that the IMT is not significant because the
media layer is dominating these measurement.
The media thickness (MT) was calculated by subtracting the IT from the IMT in
each artery. Like the IMT, the MT (Table VI) of the arteries in the transplanted hand was
not significantly different than in the native hand. The average MT of the native hand
(0.105 mm) was slightly larger than in the transplanted hand (0.101 mm). Again, since
the hallmark characteristic of chronic rejection is increased intimal thickness, it is logical
that the media thicknesses not significantly different between the arms. Chronic rejection
does not affect the medial layer.
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TABLE V
INTIMA-MEDIA THICKNESS RESULTS

Subject
1
2
3
4
Average

Subject
1
2
3
4
Average

Ulnar
0.284
0.252
0.198
0.509
0.311 ± 0.137

Ulnar
0.265
0.330
0.189
0.240
0.256 ± 0.059

Radial
0.272
0.207
0.194
0.360
0.258 ± 0.076

Radial
0.270
0.270
0.234
0.339
0.278 ± 0.044

Palmar Arch
0.127
0.225
0.259
0.204 ± 0.069

Palmar Arch
0.180
0.207
0.250
0.212 ± 0.035

Transplant IMT (mm)
Digit 1
Digit 2
0.144
0.144
0.192
0.16 ± 0.028

Digit 3
0.303
0.146
0.134
0.192
0.194 ± 0.077

Digit 4
0.235
0.138
0.137
0.228
0.185 ± 0.054

Digit 5
0.161
0.111
0.105
0.210
0.147 ± 0.049

Native IMT (mm)
Digit 1
Digit 2
0.196
0.149
0.108
0.120
0.084
0.133
0.162
0.246
0.138 ± 0.051 0.162 ± 0.057

Digit 3
0.144
0.132
0.140
0.216
0.158 ± 0.039

Digit 4
0.177
0.126
0.112
0.181
0.149 ± 0.035

Digit 5
0.134
0.144
0.112
0.210
0.15 ± 0.042

0.114
0.138
0.126 ± 0.017
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TABLE VI
MEDIA THICKNESS RESULTS

Subject
1
2
3
4
Average

Subject
1
2
3
4
Average

Ulnar
0.132
0.130
0.077
0.369
0.177 ± 0.131

Ulnar
0.176
0.246
0.080
0.140
0.161 ± 0.069

Radial
0.154
0.090
0.073
0.215
0.133 ± 0.065

Radial
0.180
0.162
0.117
0.219
0.17 ± 0.042

Palmar Arch
0.033
0.117
0.139
0.096 ± 0.056

Palmar Arch
0.081
0.117
0.130
0.109 ± 0.025

Transplant MT (mm)
Digit 1
Digit 2

Digit 3
0.229
0.043
0.059
0.101
0.108 ± 0.084

Digit 4
0.135
0.041
0.058
0.126
0.09 ± 0.047

Digit 5
0.066
0.006
0.021
0.078
0.043 ± 0.035

Native MT (mm)
Digit 1
Digit 2
Digit 3
0.112
0.097
0.041
0.036
0.066
0.072
0.020
0.063
0.077
0.108
0.162
0.150
0.069 ± 0.048 0.097 ± 0.046 0.085 ± 0.046

Digit 4
0.098
0.060
0.035
0.114
0.077 ± 0.036

Digit 5
0.050
0.054
0.043
0.150
0.074 ± 0.051

0.054
0.072
0.063 ± 0.013
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0.053
0.054
0.090
0.066 ± 0.021

5.2.3 Lumen diameter
The UBM examinations showed that all of the arteries examined were patent,
allowing adequate blood flow to the hand. Results of the Kruskal-Wallis statistical
analysis found that lumen diameter was near statistical significance with p=0.066. On
average, lumen diameters were smaller in the transplanted hand of all four patients. The
largest lumen diameter difference was seen in the radial artery, where the lumen diameter
was 0.956 mm smaller in transplanted hand on average compared to the native hand
across all four patients.
Lumen diameter measurements provide valuable information about the crosssectional area through which the blood passes. If the lumen diameter is very small, less
blood will be able to be delivered. In the Louisville CTA hand transplant recipient who
lost their graft, histological analysis of several arteries, including radial and ulnar arteries,
revealed diminutive lumen diameters due to severe intimal hyperplasia. The area that had
been part of the lumen was overcome by the rapidly growing intima. The catastrophic
result was almost complete restriction of blood flow to the hand, which finally led to
thrombosis and amputation of the graft. This patient was on the lowest initial dose of
immunosuppression that the Louisville CTA program had used, with only two drugs and
no steroids. Thus, chronic rejection manifested into a catastrophic event much more
quickly than expected. If the clinicians had the UBM system used in this study, they may
have been able to salvage the patient’s arm by implementing alternative drug therapies to
halting the IH growth. They would have known how severe the patient’s IH was in realtime, without the need for histological analysis of a biopsy.
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TABLE VII
LUMEN DIAMETER RESULTS

Subject
1
2
3
4
Average

Subject
1
2
3
4
Average

Ulnar
1.972
2.341
2.075
2.116
2.126 ± 0.156

Ulnar
1.972
1.389
3.182
1.427
1.993 ± 0.837

Radial
1.432
1.662
1.681
3.198
1.993 ± 0.811

Radial
2.066
2.847
3.621
3.264
2.95 ± 0.669

Palmar Arch
1.385
0.853
1.348
1.195 ± 0.297

Palmar Arch
1.638
1.949
0.918
1.502 ± 0.529

Transplant LD (mm)
Digit 1
Digit 2
0.671
0.943
1.019
0.878 ± 0.183

Digit 3
0.515
0.870
0.971
1.032
0.847 ± 0.231

Digit 4
0.593
0.907
0.780
0.833
0.778 ± 0.134

Digit 5
0.409
0.761
0.797
0.683
0.663 ± 0.176

Native LD (mm)
Digit 1
Digit 2
0.895
0.731
1.079
1.013
1.432
1.594
0.521
0.977
0.982 ± 0.379 1.079 ± 0.366

Digit 3
0.677
1.347
1.663
0.982
1.167 ± 0.429

Digit 4
1.028
0.869
1.251
0.826
0.994 ± 0.192

Digit 5
1.053
0.946
1.195
0.946
1.035 ± 0.118

0.576
0.725
0.651 ± 0.105
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5.2.4 Intima-to-lumen diameter ratios
One goal of the project was to compare the IT-to-LD ratio of the arteries in the
transplanted hand to those in the native hand. Again using the Kruskal-Wallis statistical
analysis, it was found that the average IT-to-LD ratios among the four patients were
significantly (p=0.000) larger in the transplanted hand (0.105 ± 0.042) compared to the
native hand (0.066 ± 0.028). Thus, the second hypothesis is accepted.
This parameter is important to consider since it was normalized to each patient.
The largest IT-to-LD ratio found was in the fifth digit of the transplanted hand in patient
1 (Table VIII). Interestingly, this artery was also the artery with the lowest digital
brachial index of 0.69. Again, the results seen are due to the effects of chronic rejection
of the transplanted grafts. Chronic rejection increases the IH, and increases the IT-to-LD
ratio. Because this is a normalized value, it provides the ability to compare
measurements between arms and between patients. Comparisons are more meaningful
since this parameter is normalized. Of all of the parameters evaluated, the IT-to-LD ratio
most directly quantifies the patency of the vessel. The ratio shows how large the intima
is in relation to the lumen diameter, which allows interpretation of the severity of IH
(and, thus, chronic rejection). The IT-to-LD ratio is a vital parameter to monitor in these
patients in the future.
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TABLE VIII
INTIMA-TO-LUMEN DIAMETER RESULTS

Subject
1
2
3
4
Average

Ulnar
0.081
0.052
0.058
0.066
0.064 ± 0.013

Radial
0.083
0.070
0.072
0.045
0.068 ± 0.016

Subject
1
2
3
4
Average

Ulnar
0.046
0.060
0.034
0.070
0.053 ± 0.016

Radial
0.043
0.038
0.032
0.037
0.037 ± 0.005

Palmar Arch
0.068
0.126
0.089
0.094 ± 0.03

Palmar Arch
0.060
0.046
0.131
0.079 ± 0.046

Transplant IT/LD
Digit 1
Digit 2
0.104
0.091
0.098 ± 0.009

0.135
0.095
0.100
0.11 ± 0.022

Native IT/LD
Digit 1
Digit 2
0.094
0.071
0.067
0.053
0.045
0.044
0.104
0.086
0.077 ± 0.027 0.064 ± 0.019
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Digit 3
0.144
0.119
0.077
0.088
0.107 ± 0.03

Digit 3
0.151
0.044
0.038
0.067
0.075 ± 0.052

Digit 4
0.168
0.106
0.101
0.122
0.124 ± 0.03

Digit 4
0.076
0.076
0.061
0.081
0.073 ± 0.009

Digit 5
0.232
0.138
0.105
0.193
0.167 ± 0.057

Digit 5
0.080
0.095
0.058
0.063
0.074 ± 0.017

5.2.6 Intima-media-to-lumen diameter ratio and media-to-lumen diameter ratios
The IMT-to-lumen diameter ratio (Table IX) was found to be significantly
(p=0.035) larger in the transplanted hand. The average IMT-to-lumen ratio in the
transplant hand was 0.2030, while the average in the native hand was 0.1504. These
results were interesting considering that the IMT data between patients was not found to
be significant. This suggested that for this normalized parameter, the effect of IH has a
greater influence on the statistical significance compared to the IMT data alone. The
normalized data enhances the effects of variability between the transplanted and native
hands by making all measurements more accurately comparable. Thus, the effects of
chronic rejection are more easily recognized in a normalized parameter.
The MT-to-lumen ratio (Table X) was not significantly different in opposing
hands. The average MT-to-lumen ratio in the transplant hand was 0.0983. Similarly, the
average MT-to-lumen ratio in the native hand was 0.0841. Again, since chronic rejection
affects the intima, these results are logical. The normalized data still provides a more
accurate comparison between hands and between patients. Yet, this parameter was not
significant, as expected. This helps confirm the poorly understood notion that chronic
rejection manifests as IH, and does not have significant effects on the media layer.
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TABLE IX
INTIMA-MEDIA-TO-LUMEN DIAMETER RESULTS

Subject
1
2
3
4
Average

Subject
1
2
3
4
Average

Ulnar
0.152
0.108
0.096
0.241
0.149 ± 0.066

Ulnar
0.135
0.237
0.059
0.168
0.15 ± 0.074

Radial
0.190
0.124
0.115
0.113
0.136 ± 0.037

Radial
0.131
0.095
0.064
0.104
0.099 ± 0.028

Palmar Arch
0.091
0.263
0.192
0.182 ± 0.086

Palmar Arch
0.110
0.106
0.272
0.163 ± 0.095

Transplant IMT/LD
Digit 1
Digit 2
0.198
0.190
0.194 ± 0.006

0.214
0.152
0.188
0.185 ± 0.031

Native IMT/LD
Digit 1
Digit 2
0.219
0.203
0.100
0.118
0.059
0.083
0.311
0.252
0.172 ± 0.115 0.164 ± 0.077
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Digit 3
0.588
0.168
0.138
0.186
0.27 ± 0.213

Digit 3
0.212
0.098
0.084
0.220
0.154 ± 0.072

Digit 4
0.396
0.152
0.176
0.274
0.25 ± 0.111

Digit 4
0.172
0.145
0.089
0.219
0.156 ± 0.054

Digit 5
0.393
0.145
0.131
0.307
0.244 ± 0.127

Digit 5
0.128
0.152
0.094
0.222
0.149 ± 0.054

TABLE X
MEDIA-TO-LUMEN DIAMETER RESULTS

Subject
1
2
3
4
Average

Ulnar
0.071
0.056
0.037
0.174
0.085 ± 0.061

Radial
0.107
0.054
0.043
0.067
0.068 ± 0.028

Subject
1
2
3
4
Average

Ulnar
0.089
0.177
0.025
0.098
0.097 ± 0.062

Radial
0.087
0.057
0.032
0.067
0.061 ± 0.023

Palmar Arch
0.024
0.137
0.103
0.088 ± 0.058

Palmar Arch
0.049
0.060
0.142
0.084 ± 0.051

Transplant MT/LD
Digit 1
Digit 2
0.079
0.057
0.088
0.075 ± 0.016

Digit 3
0.444
0.049
0.061
0.098
0.163 ± 0.188

Digit 4
0.228
0.046
0.075
0.151
0.125 ± 0.082

Digit 5
0.161
0.008
0.026
0.114
0.077 ± 0.073

Native MT/LD
Digit 1
Digit 2
0.125
0.132
0.033
0.065
0.014
0.039
0.207
0.166
0.095 ± 0.089 0.101 ± 0.059

Digit 3
0.061
0.053
0.046
0.153
0.078 ± 0.05

Digit 4
0.095
0.069
0.028
0.138
0.083 ± 0.046

Digit 5
0.047
0.057
0.036
0.159
0.075 ± 0.057

0.094
0.099
0.097 ± 0.004
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5.3 Blood pressure measurement
The blood pressure of each patient was recorded before and after each UBM exam
to check for any effects that the blood pressures may have on the other parameters and to
check for significant changes in blood pressure during the examination. In addition,
alterations in the blood pressure provided more insight into possible causes of
unaccounted variability in other parameters.

Patients 2 and 3 had slightly high blood

pressure recordings. Patient 3 is on medication to help with his high blood pressure.
Changes in blood pressure have potential implications on parameters investigated in this
study, most notably, lumen diameter. To a certain point, higher blood pressures indicate
larger lumen diameters, while low blood pressures indicate smaller lumen diameters.
None of the patients exhibited large changes in blood pressure before and after the UBM
examination.
TABLE XI
BLOOD PRESSURE RESULTS
Patient 1
BP Before 116/68
BP After
128/70
Patient 2
BP Before 142/82
BP After
150/82
Patient 3
BP before 150/96
BP after
150/96
Patient 4
BP before 120/80
BP after
128/88

56

5.4 Oxygen saturation measurements
The oxygen saturation measurements did not vary much between patients or
between hands. Oxygen saturation is a relative measure of the amount of oxygen that is
dissolved or carried in a given medium. The results indicate that the digits analyzed have
about the same level of oxygenation. Since oxygen is carried in the blood stream, it is an
indirect indication of perfusion. The results showed that these digits are receiving
enough oxygen and are being adequately perfused. All measurements (Table XII) ranged
between 94% and 98%, with no significant differences noted. Oxygen saturations in the
transplanted hand averaged 96.6% and those in the native hand averaged 96.4%.
TABLE XII
OXYGEN SATURATION RESULTS

Subject
1
2
3
4

Transplant Oxygen saturation (%)
Digit 3
Digit 4
Digit 5
94
96
95
97
96
96
97
97
97
98
98
98

Subject
1
2
3
4

Native Oxygen saturation (%)
Digit 3
Digit 4
Digit 5
96
96
96
97
96
95
97
97
97
97
96
97

5.5 Hoop stress calculation for arterial wall
The hoop stress was found to be significantly (p=0.010) lower in the arteries of
the transplanted hand. The average hoop stress (Table XIII) calculated for the
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transplanted hand was 52.46 kPa, while the hoop stress for the native hand was 81.08
kPa. This conclusion is logical, considering that arteries in the transplanted hand have
slightly lower pressures, smaller lumen diameters, and increased wall thicknesses. Lower
pressures lead to lower hoop stress since the hoop stress is directly related to pressure.
Similarly, smaller LD lead to smaller hoop stress values since it is also directly related to
hoop stress. Furthermore, increased wall thicknesses lead to smaller hoop stress since
wall thickness is inversely proportional to hoop stress. Combining these factors into the
equation for hoop stress would result in a lower result. Increasing the wall thickness also
increases the vessel stiffness. It is well documented that as people get older, their arteries
tend to stiffen (Choi, 2010; Safar, 2000; Weber, 2004). It has also been observed that the
progression of IH increases with age (Subbotin, 2007; Osika, 2007). These observations
are related since increased IH results in thicker arterial walls, and thicker walls create
stiffer vessels. Increased stiffness (caused by increased wall thickness) would have
decreased hoop stress since hoop stress is inversely proportional to wall thickness. Thus,
progressing IH should result in lower hoop stress values.
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TABLE XIII
HOOP STRESS RESULTS

Subject
1
2
3
4
Average

Subject
1
2
3
4
Average

Ulnar
62.76
93.40
94.83
39.91
72.7 ± 26.4

Ulnar
78.72
44.95
160.3
63.42
86.8 ± 50.9

Radial
49.06
76.70
78.56
84.09
72.1 ± 15.7

Radial
75.02
129.9
153.00
109.11
116.8 ± 33.1

Transplant Hoop Stress (kPa)
Digit 1
Digit 2
Digit 3
13.38
43.50
38.58
50.00
54.26
67.70
44.48
48.12
52.31
44 ± 0.7 47 ± 7.9
45.8 ± 23

Native Hoop Stress (kPa)
Digit 1
Digit 2
Digit 3
35.3
43.57
44.26
80.75
74.39
87.95
146.91
122.51
104.71
30.01
45.80
45.16
73.2 ± 54.1 71.6 ± 36.7 70.5 ± 30.6

59

Digit 4
17.51
57.93
45.43
33.37
38.6 ± 17.2

Digit 4
50.05
65.86
144.01
51.11
77.8 ± 44.8

Digit 5
16.96
60.03
58.32
30.35
41.4 ± 21.2

Digit 5
69.96
64.97
105.51
42.94
70.8 ± 25.9

5.6 Comparisons of intima and lumen diameter to brachial indices
5.6.1 Comparison of IT and brachial index measurements
The Pearson correlation coefficient for IT and brachial indices is 0.109 (p=0.438).
Statistical significance was defined as a p-value less than 0.05, indicating a significant
relationship between the parameters tested. A Pearson correlation coefficient of +1
would indicate a perfect positive (increasing) linear relationship. A Pearson correlation
coefficient of -1 would indicate a perfect negative (decreasing) linear relationship. A
Pearson correlation coefficient of 0 would indicate that the variables are not correlated
with one another.
The high p-value here suggests there is no significant relationship between IT and
brachial index measurements. In fact, if there were a relationship between these
parameters, the Pearson correlation coefficient would be negative. Since clinicians
consider low brachial indices to indicate obstructions that could compromise flow, as
with IH, a low brachial index was expected to correlate with a high IT. These results
suggest that brachial index measurements should not be used to predict intima
thicknesses in hand transplant patients. Since IT thicknesses are a direct indication of IH,
brachial index measurements do not correlate with levels of arteriopathy in these patients.
Figure 9 illustrates the lack of a significant relationship between IT and brachial index.
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Brachial Index vs. IT
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FIGURE 9 – Plot of brachial index vs. intima thickness

5.6.2 Comparison of IT-to-lumen diameter and brachial index measurements
The Pearson correlation coefficient between IT-to-lumen diameters and brachial
index measurements was found to be -0.368 (p=0.007). . This p-value indicates a
significant relationship between IT-to-LD and brachial index. However, both the low
correlation coefficient and examination of the plot of IT-to-LD (Figure 10) indicate that
there is much variation and the regression line is a poor fit. Thus, brachial index
measurements cannot reliably predict IT-to-lumen diameter ratios in hand transplant
patients. This is valuable considering that both IT-to-lumen diameter and brachial
indices are normalized values, which provides a more accurate comparison. Since IT-tolumen diameter is a measure of arteriopathy and the correlation between it and brachial
index is not strong, brachial index measurements do not correlate with levels of
arteriopathy. From the results here and from the correlation between IT and brachial
index, hypotheses 3 and 4 are accepted. The sample size of this study was small;
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however, it included all of the remaining patients from the Louisville CTA program. The
sample size could be increased by included any new hand transplant programs that are
established in the United States. The results from this study suggest that the use of
brachial indices to eliminate the suspicion of IH is invalid. In addition, since IH is such a
strong indication of chronic rejection, the use of brachial indices to assess chronic
rejection may also be invalid; a larger sample size is needed to confirm.
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FIGURE 10 -- Plot of brachial index vs. IT-to-LD

5.6.3 Comparison of IMT-to-lumen diameter and brachial index measurements
The Pearson correlation coefficient between IMT-to-lumen diameters and brachial
index measurements was found to be -0.154 (p=0.271). Again, this high p-value suggests
that there is not a relationship between IMT-to-lumen diameter and brachial index. Thus,
brachial index measurements cannot predict IMT-to-lumen diameter ratios in hand
transplant patients.
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VI. CONCLUSIONS
The following conclusions have been established based upon the results of this study.
Though this study included all available patients at the Louisville CTA program,
increasing the sample the size of this study would be beneficial.
•

Intima thicknesses are significantly larger in the transplanted arm than in the
native arm in a hand transplant patient.

•

The intima-to-lumen diameter ratios are significantly larger in the transplanted
hand than in the native hand in a hand transplant patient.

•

Hoop stress in the arterial wall is significantly lower in the transplanted hand than
in the native hand of a hand transplant patient.

•

The UBM provides an accurate, repeatable and real-time method to investigate
the arteriopathy of a hand transplant patient.

•

The UBM provides a way for clinicians to monitor the progression of arteriopathy
in the hand, including intimal hyperplasia, over time.
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VII. RECOMMENDATIONS
To take this project further, there are many recommendations, as there are still
many unanswered questions. First, the UBM measurement protocol described here
should be added to the remaining hand transplant patients’ annual examination in the
Louisville CTA Program. Future patients should start with an UBM examination pretransplantation and, if possible, the donated graft should also be examined either before
or soon after transplantation. Due to inflammation and swelling after surgery, it may not
be possible to perform an UBM examination until several weeks after the surgery.
Nonetheless, it should be done in order to track changes in IT, IT-to-LD, IMT-to-LD and
the overall arteriopathy over time to better understand chronic rejection and the
mechanisms and/or factors associated with chronic rejection.
The pulse Doppler mode of the UBM must be investigated more closely. The
author found that when examining an arterial section with the UBM machine, a cine loop
of images could be obtained at one frequency, but a velocity waveform could not be
detected. Thus, separate, careful, detailed velocity measurements need to be obtained to
provide hemodynamic information. Velocity measurements are a better indicator of
blood flow. The ultimate cause of amputation of a CTA is significantly reduced blood
flow, velocity measurements are imperative to monitor. The velocity should be used as a
better predictor of intimal hyperplasia. In addition, the UBM system should be
characterized for humans and adjustments to the beam angle should be investigated to
compare velocity measurements made in the same artery at the same time with different
beam angles.

65

Once the Doppler mode is better understood, the wall shear stress should be
determined for each of the arteries included in this study. It has been shown that low
shear stress, oscillating shear forces at the arterial floor and the heel of an anastomosis, as
well as a high wall shear stress gradient at the toe of an anastomosis likely accelerate the
IH growth (Haruguchi, 2003). The wall shear stress must be calculated at increments
distally along the arterial tree utilizing a normalized length-to-diameter ratio for the
respective artery under investigation to elucidate whether IT or IH is localized or
distributed along the entire length of the artery. Using an MRI scan of the arms would
facilitate this and provide the framework for a computation model of the patient’s
vasculature. The MRI will collect the anatomical data of the vascular structures. This
data will be digitized into a CAD model and imported into a computational flow
dynamics (CFD) software package to attain wall shear data using the velocity/flow and
pressure data obtained from the UBM and Flo-Lab, which will be used as input
parameters for the computational modeling.
Further improvements to the analysis methods could be incorporated by
integrating an automation system to make the measurements. Finding a common
anatomical location to start at, measurements could be taken at normalized increments
downstream to the distal end of the artery. Data from different patients could be aligned
to create a standard protocol for analysis. This would eliminate the error associated with
intra-observer variability. In addition, it would create a more robust analysis of the data.
This could be done for each patient and monitored over time.
An investigation of the parameters used in this project in a larger sample of
clinically normal individuals should also be conducted to determine the variability of
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these parameters in a larger population, since small levels of intimal hyperplasia are
normal. In addition, factors such as smoking, age, gender, and hand dominance can be
explored to determine their effect on intimal hyperplasia. The intima thicknesses of the
hand transplant patients can be compared to those of the normal population to better
assess the level of arteriopathy that is present in these patients.
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